UniProt ID | M3K14_HUMAN | |
---|---|---|
UniProt AC | Q99558 | |
Protein Name | Mitogen-activated protein kinase kinase kinase 14 | |
Gene Name | MAP3K14 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 947 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Lymphotoxin beta-activated kinase which seems to be exclusively involved in the activation of NF-kappa-B and its transcriptional activity. Promotes proteolytic processing of NFKB2/P100, which leads to activation of NF-kappa-B via the non-canonical pathway. Could act in a receptor-selective manner.. | |
Protein Sequence | MAVMEMACPGAPGSAVGQQKELPKAKEKTPPLGKKQSSVYKLEAVEKSPVFCGKWEILNDVITKGTAKEGSEAGPAAISIIAQAECENSQEFSPTFSERIFIAGSKQYSQSESLDQIPNNVAHATEGKMARVCWKGKRRSKARKKRKKKSSKSLAHAGVALAKPLPRTPEQESCTIPVQEDESPLGAPYVRNTPQFTKPLKEPGLGQLCFKQLGEGLRPALPRSELHKLISPLQCLNHVWKLHHPQDGGPLPLPTHPFPYSRLPHPFPFHPLQPWKPHPLESFLGKLACVDSQKPLPDPHLSKLACVDSPKPLPGPHLEPSCLSRGAHEKFSVEEYLVHALQGSVSSGQAHSLTSLAKTWAARGSRSREPSPKTEDNEGVLLTEKLKPVDYEYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEYKEPRHPPPNQANYHQTLHAQPRELSPRAPGPRPAEETTGRAPKLQPPLPPEPPEPNKSPPLTLSKEESGMWEPLPLSSLEPAPARNPSSPERKATVPEQELQQLEIELFLNSLSQPFSLEEQEQILSCLSIDSLSLSDDSEKNPSKASQSSRDTLSSGVHSWSSQAEARSSSWNMVLARGRPTDTPSYFNGVKVQIQSLNGEHLHIREFHRVKVGDIATGISSQIPAAAFSLVTKDGQPVRYDMEVPDSGIDLQCTLAPDGSFAWSWRVKHGQLENRP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Ubiquitination | GSAVGQQKELPKAKE CCCCCCCCCCCCHHH | 54.02 | - | |
29 | Phosphorylation | LPKAKEKTPPLGKKQ CCCHHHCCCCCCCCC | 31.09 | 23532336 | |
37 | Phosphorylation | PPLGKKQSSVYKLEA CCCCCCCCCEEEEEE | 30.56 | 28796482 | |
38 | Phosphorylation | PLGKKQSSVYKLEAV CCCCCCCCEEEEEEE | 27.29 | 28796482 | |
40 | Phosphorylation | GKKQSSVYKLEAVEK CCCCCCEEEEEEECC | 16.29 | 28796482 | |
41 | Ubiquitination | KKQSSVYKLEAVEKS CCCCCEEEEEEECCC | 37.38 | - | |
47 | Ubiquitination | YKLEAVEKSPVFCGK EEEEEECCCCCCCCC | 54.16 | - | |
54 | Ubiquitination | KSPVFCGKWEILNDV CCCCCCCCHHHHHCH | 42.72 | - | |
64 | Ubiquitination | ILNDVITKGTAKEGS HHHCHHCCCCCCCCC | 43.04 | - | |
106 | Ubiquitination | RIFIAGSKQYSQSES EEEEECCCCCCCCCC | 52.95 | 21906983 | |
125 | Phosphorylation | PNNVAHATEGKMARV CCCHHHHCCCCCHHH | 35.09 | - | |
128 | Ubiquitination | VAHATEGKMARVCWK HHHHCCCCCHHHHHC | 24.13 | 21906983 | |
163 | Ubiquitination | HAGVALAKPLPRTPE HHHHHHCCCCCCCCC | 48.19 | 21906983 | |
198 | Ubiquitination | RNTPQFTKPLKEPGL CCCCCCCCCCCCCCH | 50.03 | - | |
201 | Ubiquitination | PQFTKPLKEPGLGQL CCCCCCCCCCCHHHH | 71.09 | - | |
241 | Ubiquitination | QCLNHVWKLHHPQDG HHHHHHHHCCCCCCC | 36.53 | - | |
261 | Phosphorylation | PTHPFPYSRLPHPFP CCCCCCCCCCCCCCC | 27.81 | - | |
276 | Ubiquitination | FHPLQPWKPHPLESF CCCCCCCCCCCHHHH | 39.88 | - | |
294 | Ubiquitination | LACVDSQKPLPDPHL HHCCCCCCCCCCCCH | 53.10 | 21906983 | |
352 | Phosphorylation | VSSGQAHSLTSLAKT CCCCCCHHHHHHHHH | 36.04 | 22210691 | |
354 | Phosphorylation | SGQAHSLTSLAKTWA CCCCHHHHHHHHHHH | 25.39 | - | |
365 | Phosphorylation | KTWAARGSRSREPSP HHHHHCCCCCCCCCC | 22.87 | 20068231 | |
367 | Phosphorylation | WAARGSRSREPSPKT HHHCCCCCCCCCCCC | 42.57 | 20068231 | |
385 | Ubiquitination | EGVLLTEKLKPVDYE CCCEEEEECCCCCCH | 57.48 | - | |
387 | Ubiquitination | VLLTEKLKPVDYEYR CEEEEECCCCCCHHH | 54.80 | - | |
410 | Phosphorylation | QLRLGRGSFGEVHRM CCCCCCCCCCCEECC | 28.81 | 27251275 | |
429 | Ubiquitination | TGFQCAVKKVRLEVF CCCCCEEEEHHEEEE | 27.33 | PubMed | |
549 | Phosphorylation | QPDGLGKSLLTGDYI CCCCCCHHHCCCCCC | 27.15 | 29759185 | |
552 | Phosphorylation | GLGKSLLTGDYIPGT CCCHHHCCCCCCCCC | 33.04 | 29759185 | |
559 | Phosphorylation | TGDYIPGTETHMAPE CCCCCCCCCCCCCCC | 32.15 | 29759185 | |
561 | Phosphorylation | DYIPGTETHMAPEVV CCCCCCCCCCCCCHH | 19.45 | 29759185 | |
643 | Phosphorylation | KEPIHRVSAAELGGK CCCCCCCCHHHHHHH | 23.01 | - | |
682 | Phosphorylation | PPPNQANYHQTLHAQ CCCCCCCCCHHHCCC | 9.79 | - | |
814 | Phosphorylation | DDSEKNPSKASQSSR CCCCCCCCHHCHHHH | 50.69 | - | |
817 | Phosphorylation | EKNPSKASQSSRDTL CCCCCHHCHHHHHHH | 34.04 | - | |
820 | Phosphorylation | PSKASQSSRDTLSSG CCHHCHHHHHHHHHC | 26.91 | - | |
823 | Phosphorylation | ASQSSRDTLSSGVHS HCHHHHHHHHHCCCC | 27.68 | 30576142 | |
825 | Phosphorylation | QSSRDTLSSGVHSWS HHHHHHHHHCCCCCC | 27.43 | 30576142 | |
830 | Phosphorylation | TLSSGVHSWSSQAEA HHHHCCCCCCCHHHH | 26.67 | 30576142 | |
882 | Ubiquitination | IREFHRVKVGDIATG EEEEEEEEHHHHCCC | 40.22 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
814 | S | Phosphorylation | Kinase | IKKA | O15111 | PSP |
817 | S | Phosphorylation | Kinase | IKKA | O15111 | PSP |
820 | S | Phosphorylation | Kinase | IKKA | O15111 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | ZFP91 | Q96JP5 | PMID:20682767 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF3 | Q13114 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF1 | Q13077 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | BIRC3 | Q13489 | PMID:18022362 |
- | K | Ubiquitination | E3 ubiquitin ligase | BIRC2 | Q13490 | PMID:18022362 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF2 | Q12933 | PMID:22199232 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M3K14_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"An atypical E3 ligase zinc finger protein 91 stabilizes and activatesNF-kappaB-inducing kinase via Lys63-linked ubiquitination."; Jin X., Jin H.R., Jung H.S., Lee S.J., Lee J.H., Lee J.J.; J. Biol. Chem. 285:30539-30547(2010). Cited for: PHOSPHORYLATION AT THR-559, UBIQUITINATION, INTERACTION WITH ZFP91,AND MUTAGENESIS OF 429-LYS-LYS-430 AND THR-559. |